Parkman Healthcare Partners LLC - Q2 2023 holdings

$577 Million is the total value of Parkman Healthcare Partners LLC's 95 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 45.8% .

 Value Shares↓ Weighting
UTHR BuyUNITED THERAPEUTICS CORP DEL$27,147,394
+12.2%
122,978
+13.8%
4.71%
-10.6%
BSX BuyBOSTON SCIENTIFIC CORP$25,590,249
+19.4%
473,105
+10.5%
4.44%
-4.8%
SDGR BuySCHRODINGER INC$24,092,690
+129.2%
482,626
+20.9%
4.18%
+82.7%
BDX BuyBECTON DICKINSON & CO$22,083,380
+124.2%
83,646
+110.2%
3.83%
+78.7%
THC BuyTENET HEALTHCARE CORP$20,673,531
+87.2%
254,037
+36.7%
3.58%
+49.2%
LNTH BuyLANTHEUS HLDGS INC$20,606,304
+33.3%
245,547
+31.2%
3.57%
+6.3%
PODD BuyINSULET CORP$16,738,425
+82.6%
58,051
+102.0%
2.90%
+45.5%
ABC NewAMERISOURCEBERGEN CORP$16,597,08886,250
+100.0%
2.88%
IMGN NewIMMUNOGEN INC$15,866,104840,811
+100.0%
2.75%
COO SellCOOPER COS INC$15,384,362
-21.3%
40,123
-23.4%
2.67%
-37.3%
DHR BuyDANAHER CORPORATION$14,567,040
+279.8%
60,696
+298.9%
2.52%
+202.8%
BuyRXSIGHT INC$14,360,573
+101.3%
498,631
+16.6%
2.49%
+60.4%
NBIX SellNEUROCRINE BIOSCIENCES INC$13,177,011
-40.2%
139,735
-35.9%
2.28%
-52.4%
PCVX BuyVAXCYTE INC$11,411,540
+63.6%
228,505
+22.8%
1.98%
+30.4%
KROS BuyKEROS THERAPEUTICS INC$11,122,427
+45.3%
276,815
+54.4%
1.93%
+15.8%
DXCM BuyDEXCOM INC$10,939,542
+19.3%
85,126
+7.9%
1.90%
-4.9%
WAT BuyWATERS CORP$10,844,980
+195.2%
40,688
+242.9%
1.88%
+135.3%
KRTX BuyKARUNA THERAPEUTICS INC$10,676,176
+49.5%
49,233
+25.3%
1.85%
+19.2%
SILK BuySILK RD MED INC$9,991,487
+6.5%
307,525
+28.2%
1.73%
-15.1%
HAE SellHAEMONETICS CORP MASS$9,796,294
-15.9%
115,061
-18.2%
1.70%
-33.0%
ANIP BuyANI PHARMACEUTICALS INC$9,392,097
+136.5%
174,477
+74.5%
1.63%
+88.4%
VRNA SellVERONA PHARMA PLCsponsored ads$8,476,865
-13.5%
400,987
-17.8%
1.47%
-31.1%
XENE SellXENON PHARMACEUTICALS INC$8,382,990
-15.5%
217,740
-21.5%
1.45%
-32.7%
DCPH BuyDECIPHERA PHARMACEUTICALS IN$8,071,205
+6.2%
573,239
+16.6%
1.40%
-15.3%
MNKD BuyMANNKIND CORP$7,393,485
+22.3%
1,816,581
+23.2%
1.28%
-2.4%
XFOR BuyX4 PHARMACEUTICALS INC$7,307,190
+200.3%
3,766,593
+34.7%
1.27%
+139.5%
ETNB Buy89BIO INC$6,611,181
+75.8%
348,875
+41.3%
1.15%
+40.1%
IONS BuyIONIS PHARMACEUTICALS INC$6,279,724
+16.2%
153,052
+1.3%
1.09%
-7.3%
BuyARCELLX INC$6,174,121
+35.7%
195,260
+32.2%
1.07%
+8.2%
CTLT NewCATALENT INC$6,124,600141,250
+100.0%
1.06%
SUPN BuySUPERNUS PHARMACEUTICALS INC$5,716,781
+19.6%
190,179
+44.2%
0.99%
-4.6%
TGTX SellTG THERAPEUTICS INC$5,480,549
+32.2%
220,634
-20.0%
0.95%
+5.3%
VCYT BuyVERACYTE INC$5,398,621
+104.1%
211,960
+78.7%
0.94%
+62.8%
STRO BuySUTRO BIOPHARMA INC$5,318,954
+4.7%
1,143,861
+4.0%
0.92%
-16.6%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$5,113,651
-4.4%
428,279
+7.0%
0.89%
-23.9%
HUM SellHUMANA INC$4,989,971
-42.4%
11,160
-37.4%
0.86%
-54.1%
INSP NewINSPIRE MED SYS INC$4,697,54114,470
+100.0%
0.81%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$4,396,713
+39.9%
172,285
+16.6%
0.76%
+11.4%
SNDX NewSYNDAX PHARMACEUTICALS INC$4,359,007208,266
+100.0%
0.76%
SGEN SellSEAGEN INC$4,349,981
-70.6%
22,602
-69.1%
0.75%
-76.6%
PACB NewPACIFIC BIOSCIENCES CALIF IN$4,329,150325,500
+100.0%
0.75%
MMS NewMAXIMUS INC$4,257,69850,381
+100.0%
0.74%
IMVT BuyIMMUNOVANT INC$4,113,986
+42.6%
216,868
+16.6%
0.71%
+13.5%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$4,107,178
+52.5%
291,703
+16.6%
0.71%
+21.5%
NewMOONLAKE IMMUNOTHERAPEUTICSclass a ord$4,080,00080,000
+100.0%
0.71%
ESTA BuyESTABLISHMENT LABS HLDGS INC$3,985,075
+135.3%
58,083
+132.3%
0.69%
+87.8%
PFMT SellPERFORMANT FINL CORP$3,905,321
-26.1%
1,446,415
-6.9%
0.68%
-41.1%
NEO NewNEOGENOMICS INC$3,790,061235,847
+100.0%
0.66%
SIBN NewSI-BONE INC$3,747,927138,915
+100.0%
0.65%
CGEM BuyCULLINAN ONCOLOGY INC$3,731,364
+114.7%
346,781
+104.1%
0.65%
+71.2%
NTRA SellNATERA INC$3,651,398
-47.4%
75,039
-40.0%
0.63%
-58.1%
EVH SellEVOLENT HEALTH INCcl a$3,620,608
-40.3%
119,492
-36.1%
0.63%
-52.4%
EWTX BuyEDGEWISE THERAPEUTICS INC$3,520,414
+747.4%
454,247
+629.3%
0.61%
+577.8%
AKYA BuyAKOYA BIOSCIENCES INC$3,480,690
+111.3%
471,000
+133.9%
0.60%
+68.4%
SAGE BuySAGE THERAPEUTICS INC$3,292,952
+209.9%
70,033
+176.6%
0.57%
+147.2%
KRMD BuyKORU MEDICAL SYSTEMS INC$3,101,767
-13.7%
899,063
+5.6%
0.54%
-31.1%
LXRX BuyLEXICON PHARMACEUTICALS INC$3,047,111
+85.7%
1,330,616
+97.0%
0.53%
+47.9%
IDYA NewIDEAYA BIOSCIENCES INC$2,992,467127,339
+100.0%
0.52%
ESPR BuyESPERION THERAPEUTICS INC NE$2,963,910
-0.8%
2,132,309
+13.5%
0.51%
-20.9%
SWAV SellSHOCKWAVE MED INC$2,875,791
-71.7%
10,076
-78.5%
0.50%
-77.4%
BuyNEWAMSTERDAM PHARMA COMPANYordinary shares$2,842,316
+86.4%
239,051
+107.9%
0.49%
+48.5%
BDTX NewBLACK DIAMOND THERAPEUTICS I$2,525,000500,000
+100.0%
0.44%
LBPH NewLONGBOARD PHARMACEUTICALS IN$2,507,249341,587
+100.0%
0.44%
CDMO SellAVID BIOSERVICES INC$2,485,263
-70.8%
177,900
-60.8%
0.43%
-76.7%
ARVN NewARVINAS INC$2,482,000100,000
+100.0%
0.43%
LYRA NewLYRA THERAPEUTICS INC$2,466,000600,000
+100.0%
0.43%
RCUS BuyARCUS BIOSCIENCES INC$2,438,195
+29.8%
120,049
+16.6%
0.42%
+3.4%
ACAD NewACADIA PHARMACEUTICALS INC$2,395,000100,000
+100.0%
0.42%
AXGN BuyAXOGEN INC$2,381,634
+12.6%
260,858
+16.6%
0.41%
-10.2%
TVTX BuyTRAVERE THERAPEUTICS INC$2,247,521
-29.6%
146,323
+3.1%
0.39%
-43.8%
NewDISC MEDICINE INC$2,220,00050,000
+100.0%
0.38%
LQDA SellLIQUIDIA CORPORATION$2,206,902
-2.3%
281,134
-14.0%
0.38%
-22.0%
COGT BuyCOGENT BIOSCIENCES INC$2,199,659
+12.1%
185,782
+2.1%
0.38%
-10.8%
CVRX NewCVRX INC$2,173,381140,763
+100.0%
0.38%
CSTL NewCASTLE BIOSCIENCES INC$2,030,587148,002
+100.0%
0.35%
ACRS BuyACLARIS THERAPEUTICS INC$2,007,601
+49.5%
193,597
+16.6%
0.35%
+19.2%
SellMARINUS PHARMACEUTICALS INC$1,857,875
+7.7%
171,075
-31.6%
0.32%
-14.1%
NewASLAN PHARMACEUTICALS LTDspon ads new$1,849,167506,621
+100.0%
0.32%
MRUS NewMERUS N V$1,787,30767,881
+100.0%
0.31%
GRTX BuyGALERA THERAPEUTICS INC$1,687,443
+25.6%
540,847
+3.0%
0.29%
+0.3%
AKRO NewAKERO THERAPEUTICS INC$1,634,15035,000
+100.0%
0.28%
MIRM BuyMIRUM PHARMACEUTICALS INC$1,614,547
+8.2%
62,410
+0.5%
0.28%
-13.8%
TELA BuyTELA BIO INC$1,610,933
+10.2%
159,026
+15.8%
0.28%
-12.3%
IMUX BuyIMMUNIC INC$1,354,780
+97.8%
539,753
+17.4%
0.24%
+57.7%
QTRX NewQUANTERIX CORP$1,130,74750,144
+100.0%
0.20%
SLN BuySILENCE THERAPEUTICS PLCads$1,017,929
+3.4%
185,078
+16.6%
0.18%
-17.8%
INZY BuyINOZYME PHARMA INC$940,160
+31.3%
168,790
+35.0%
0.16%
+4.5%
TERN BuyTERNS PHARMACEUTICALS INC$896,219
+0.9%
102,425
+36.6%
0.16%
-19.7%
NSTG NewNANOSTRING TECHNOLOGIES INC$759,375187,500
+100.0%
0.13%
AFIB BuyACUTUS MED INC$676,678
+37.3%
762,025
+16.6%
0.12%
+9.3%
VYGR NewVOYAGER THERAPEUTICS INC$662,73757,881
+100.0%
0.12%
SVRA BuySAVARA INC$660,109
+91.0%
206,607
+16.6%
0.11%
+52.0%
TKNO BuyALPHA TEKNOVA INC$470,758
+5.1%
176,314
+16.6%
0.08%
-15.5%
BuyMINERALYS THERAPEUTICS INC$198,769
+26.9%
11,658
+16.6%
0.03%0.0%
CDTX SellCIDARA THERAPEUTICS INC$153,692
-79.8%
136,011
-77.3%
0.03%
-83.7%
GRTS ExitGRITSTONE BIO INC$0-151,921
-100.0%
-0.09%
ExitAADI BIOSCIENCE INC$0-75,961
-100.0%
-0.12%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-25,000
-100.0%
-0.36%
ExitPROCEPT BIOROBOTICS CORP$0-67,252
-100.0%
-0.42%
LEGN ExitLEGEND BIOTECH CORPsponsored ads$0-47,608
-100.0%
-0.50%
ISEE ExitIVERIC BIO INC$0-97,082
-100.0%
-0.51%
BIIB ExitBIOGEN INC$0-17,920
-100.0%
-1.08%
MDGL ExitMADRIGAL PHARMACEUTICALS INC$0-25,840
-100.0%
-1.36%
CTIC ExitCTI BIOPHARMA CORP$0-1,753,630
-100.0%
-1.60%
ZBH ExitZIMMER BIOMET HOLDINGS INC$0-65,000
-100.0%
-1.83%
IQV ExitIQVIA HLDGS INC$0-45,643
-100.0%
-1.97%
LLY ExitLILLY ELI & CO$0-27,671
-100.0%
-2.07%
ANTM ExitELEVANCE HEALTH INC$0-21,643
-100.0%
-2.16%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-11
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC16Q3 20236.3%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
XENON PHARMACEUTICALS INC16Q3 20233.3%
NATERA INC16Q3 20233.4%
AVID BIOSERVICES INC15Q3 20232.9%
SCHRODINGER INC15Q3 20234.2%
REPRO MED SYS INC15Q2 20232.0%
MANNKIND CORP15Q3 20231.6%
IQVIA HLDGS INC14Q1 20234.6%
INSULET CORP14Q3 20232.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings